IL295258A - Anti-hepsin antibodies and uses thereof - Google Patents

Anti-hepsin antibodies and uses thereof

Info

Publication number
IL295258A
IL295258A IL295258A IL29525822A IL295258A IL 295258 A IL295258 A IL 295258A IL 295258 A IL295258 A IL 295258A IL 29525822 A IL29525822 A IL 29525822A IL 295258 A IL295258 A IL 295258A
Authority
IL
Israel
Prior art keywords
cdr
seq
antibody
hepsin
nos
Prior art date
Application number
IL295258A
Other languages
English (en)
Hebrew (he)
Original Assignee
Navaux Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Navaux Inc filed Critical Navaux Inc
Publication of IL295258A publication Critical patent/IL295258A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2470/00—Immunochemical assays or immunoassays characterised by the reaction format or reaction type
    • G01N2470/04—Sandwich assay format

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL295258A 2020-02-05 2021-02-03 Anti-hepsin antibodies and uses thereof IL295258A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062970626P 2020-02-05 2020-02-05
PCT/US2021/016409 WO2021158660A2 (en) 2020-02-05 2021-02-03 Anti-hepsin antibodies and uses thereof

Publications (1)

Publication Number Publication Date
IL295258A true IL295258A (en) 2022-10-01

Family

ID=77200525

Family Applications (1)

Application Number Title Priority Date Filing Date
IL295258A IL295258A (en) 2020-02-05 2021-02-03 Anti-hepsin antibodies and uses thereof

Country Status (11)

Country Link
US (1) US20230236192A1 (enExample)
EP (1) EP4100062A4 (enExample)
JP (1) JP2023512782A (enExample)
KR (1) KR20220137696A (enExample)
CN (1) CN115427075A (enExample)
AU (1) AU2021215999A1 (enExample)
BR (1) BR112022015523A2 (enExample)
CA (1) CA3169809A1 (enExample)
IL (1) IL295258A (enExample)
MX (1) MX2022009584A (enExample)
WO (1) WO2021158660A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025259819A1 (en) * 2024-06-11 2025-12-18 Navaux, Inc. Anti-hepsin antibodies and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007524605A (ja) * 2003-04-03 2007-08-30 ピーディーエル バイオファーマ，インコーポレイティド インテグリンα５β１のインヒビターおよび組織顆粒化の制御のためのそれらの使用
US20050025763A1 (en) * 2003-05-08 2005-02-03 Protein Design Laboratories, Inc. Therapeutic use of anti-CS1 antibodies
US7029675B1 (en) * 2003-06-04 2006-04-18 Shu-Wha Lin Hepsin antagonist and methods of use
US8383351B2 (en) * 2008-06-11 2013-02-26 Oxford Brookes University Antibody to inhibin/ activin β-B subunit
WO2010082034A1 (en) * 2009-01-16 2010-07-22 University Of Exeter Antibody
RU2559533C2 (ru) * 2009-10-22 2015-08-10 Дженентек, Инк. Антитела против гепсина и способы их применения
WO2011161189A1 (en) * 2010-06-24 2011-12-29 F. Hoffmann-La Roche Ag Anti-hepsin antibodies and methods of use
CN102093479B (zh) * 2010-11-29 2012-10-03 侯宗柳 抗人血管内皮生长因子受体2的重组嵌合抗体
EP2721417A4 (en) * 2011-06-17 2015-05-06 Univ Arkansas NEW MARKERS FOR EARLY DIAGNOSIS OF EGG CANCER, MONITORING DURING THE CORRESPONDING THERAPY AND NEW THERAPY OPTIONS DURING AND AFTER THE CORRESPONDING CHEMOTHERAPY
US20180305702A1 (en) * 2015-09-15 2018-10-25 Advaxis, Inc. Listeria-Based Immunogenic Compositions And Methods Of Use Thereof in Cancer Prevention And Treatment

Also Published As

Publication number Publication date
WO2021158660A2 (en) 2021-08-12
KR20220137696A (ko) 2022-10-12
BR112022015523A2 (pt) 2022-09-27
JP2023512782A (ja) 2023-03-29
EP4100062A2 (en) 2022-12-14
CN115427075A (zh) 2022-12-02
MX2022009584A (es) 2022-10-07
US20230236192A1 (en) 2023-07-27
AU2021215999A1 (en) 2022-09-01
CA3169809A1 (en) 2021-08-12
WO2021158660A3 (en) 2021-09-23
EP4100062A4 (en) 2024-05-22

Similar Documents

Publication Publication Date Title
JP2022163179A (ja) ヒト化モノクローナル終末糖化産物抗体
CN102333542B (zh) Pcsk9拮抗剂
US20220233705A1 (en) Combined therapies of activatable immune checkpoint inhibitors and conjugated activatable antibodies
CN102844332B (zh) 呈pH依赖性抗原结合的抗体
IL261006A (en) Method and preparation for the treatment of cancer, killing of metastatic cancer cells and prevention of cancer metastases using an antibody to advanced glycation end products
IL271305A (en) Anti-NTB-A antibodies and related compositions and methods
IL292449A (en) Nucleic acids encoding antibodies against pdl1 and methods for their preparation
IL303690A (en) Anti–NTB–A antibodies and related preparations and methods
IL298034A (en) Antibodies against bet v 1 and methods of using them
CA2984945A1 (en) Anti-cd71 antibodies, activatable anti-cd71 antibodies, and methods of use thereof
NZ539395A (en) Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same
IL302592A (en) Anti-tigit antibodies and uses thereof
IL304052A (en) ANTI-GPRC5D MONOCLONAL ANTIBODIES AND THEIR USES
TW201206466A (en) Antibodies with pH dependent antigen binding
IL293195A (en) Anti-avb6 antibodies and antibody-drug conjugates
WO2018067819A1 (en) Compositions and methods for treatment of cancers
IL305264A (en) Anti-PAD4 antibodies, preparations containing them and their uses
WO2023177390A1 (en) Humanized monoclonal advanced glycation end-product antibody for treating pancreatic cancer
IL305666A (en) Anti-ALPP/ALPPL2 antibodies and antibody-drug conjugates
CN103476459A (zh) 抗凝血剂解毒剂
IL265331B2 (en) Anti-gm-csf antibodies and uses thereof
IL295258A (en) Anti-hepsin antibodies and uses thereof
WO2008154439A1 (en) Methods and compositions for inducing apoptosis in cancer cells
IL258242B2 (en) Preparations and methods for inhibiting cancer stem cells
CN114761042A (zh) Il-38特异性抗体